News
Sydney scientists have revealed why receiving a booster vaccine in the same arm as your first dose can generate a more ...
Dailymotion on MSN5h
World-first human trial aims to treat underlying cause of type 1 diabetesA world-first human trial of an immunotherapy drug to treat type 1 diabetes patients has begun after decades of work by an ...
13h
News-Medical.Net on MSNUQ begins first human trial of immunotherapy for Type 1 diabetesResearchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially ...
When it comes to getting the most out of a vaccine, arm consistency can make a difference. Some studies suggest that getting ...
Empathetic and persistent communication is key when it comes to talking to parents who are reluctant to vaccinate their child ...
Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...
Discover how the genetics behind your eye color connects to various health conditions, from melanoma risk to pain ...
A world-first human trial of a drug designed to treat the underlying cause of type 1 diabetes has begun in Australia.
Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...
12h
News Medical on MSNInfluenza virus hijacks human gene regulator to evade immune systemThe influenza virus manipulates the body's gene regulation system to accelerate its own spread, according to researchers at the University of Gothenburg.
Immune resilience driven by TCF7 promotes healthy aging and reduces mortality risks. Strengthening it during midlife can ...
The influenza virus manipulates the body's gene regulation system to accelerate its own spread, according to researchers at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results